The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
LORELEI: A phase II randomized, double-blind study of neoadjuvant letrozole plus taselisib (GDC-0032) versus letrozole plus placebo in postmenopausal women with ER-positive/HER2-negative, early-stage breast cancer.
 
Evandro De Azambuja
No Relationships to Disclose
 
Cristina Saura
No Relationships to Disclose
 
Mafalda Oliveira
No Relationships to Disclose
 
Peter Christian Dubsky
No Relationships to Disclose
 
Dimitrios Zardavas
No Relationships to Disclose
 
Christian Fesl
No Relationships to Disclose
 
Aditya Bardia
No Relationships to Disclose
 
Ray Lin
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
 
Jill O. Fredrickson
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
 
Hema Parmar
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
 
Stina Mui Singel
Employment - Genentech
Stock and Other Ownership Interests - Genentech/Roche
 
Jerry Y. Hsu
Employment - Roche Pharma AG
Stock and Other Ownership Interests - Roche Pharma AG
 
Martine J. Piccart-Gebhart
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Invivis; Lilly; MSD; Novartis; Pfizer; Roche/Genentech; Sanofi; Symphony Evolution; Synthon; Verastem
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Invivis (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi (Inst); Symphony Evolution (Inst); Synthon (Inst); Verastem (Inst)
 
Michael Gnant
Honoraria - Genentech
Research Funding - Genentech
 
Jose Baselga
Consulting or Advisory Role - Genentech